GL1X · GenesisL1 explorer

MolNFT v1 · #33064 · protein

Thrombin inhibitors

2C8W · Thrombin light chain: “Thrombin inhibitors”. X-ray diffraction, 2 ligands (C7M, NA), 2 pockets (best druggability 0.57). MolNFT v1 #33064 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
2C8W
Type
protein
Length
290 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Thrombin light chain; Thrombin heavy chain; Hirudin variant-2
EC
3.4.21.5
UniProt
P00734, P09945
Ligands
C7M, NA
Pockets
2 · best druggability 0.57

Structure

x-ray diffraction · 3 distinct chains · 18% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AThrombin light chain (EC 3.4.21.5)protein2934% helix, 0% strandP00734
BThrombin heavy chain (EC 3.4.21.5)protein25116% helix, 35% strandP00734
IHirudin variant-2protein1030% helix, 0% strandP09945

Ligands and binding sites

  • C7M · (2S,3R)-N-[5-chloro-2-(2,3-dihydro-1H-tetrazol-1-yl)benzyl]-3-hydroxy-4-{[(4-methoxyphenyl)sulfonyl]amino}-1-phenylbuta N-2-aminium · ligand · chains B
  • NA · Sodium ion · metal · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13050.570.7738C7M
2850.350.7513empty

Interfaces

2 interfaces between chains.

  • A–B · 1179 Ų buried · 26 hydrogen bonds · protein-protein
  • B–I · 645 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide, 1 modified (disulfide, sulfation).

Compared structures

  • 2C8W · thrombin inhibitors · the same entry in another collection · chain I against I, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.